发明名称 |
Topical pharmaceutical composition comprising nanonized silver sulfadiazine |
摘要 |
The invention relates to a topical pharmaceutical composition for burn treatment and microbial infections on human beings or animals. The pharmaceutical composition comprises 0.1% w/w to 1.0% w/w of an antimicrobial drug, i.e., silver sulfadiazine and 0.2% w/w antiseptic, i.e., chlorhexidine gluconate, wherein silver sulfadiazine is in nanonized form. |
申请公布号 |
US9433580(B2) |
申请公布日期 |
2016.09.06 |
申请号 |
US201313762792 |
申请日期 |
2013.02.08 |
申请人 |
SUN PHARMACEUTICAL INDUSTRIES LIMITED |
发明人 |
Gupta Neeta;Bedi Simrata;Srivastava Jyoti;Arora Vinod Kumar;Pandya Manisha;Shingatgeri Vyas M.;Bhelonde Jaiprakash Jaysingrao;Obrah Monika;Sharma Sanjay Kumar;Jalali Rajinder K.;Arora Sudershan Kumar |
分类号 |
A61K9/14;A61K31/555;A61K31/155;A61K9/00;A61K33/38;A61K31/635 |
主分类号 |
A61K9/14 |
代理机构 |
|
代理人 |
|
主权项 |
1. A topical pharmaceutical composition consisting of 0.1% w/w to 1.0% w/w silver sulfadiazine, 0.2% w/w chlorhexidine gluconate, and one or more pharmaceutically acceptable excipients wherein silver sulfadiazine has a Z-average particle size between 150 nm and 500 nm. |
地址 |
Mumbai IN |